Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HDM1005 Compared to Tirzepatide in Obese Adults Without Diabetes
NCT07521631Phase 2Recruiting
- Sponsor
- Huadong Medicine
- Start
- Mar 2026
- Primary completion
- Feb 2027
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of poterepatide in obesity, sponsored by Huadong Medicine. Started Mar 2026; status: recruiting.
02
Drugs
poterepatide
03
Conditions
obesity
Beyond the preview
Go deeper on NCT07521631.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07521631.